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Lung cancer, is the leading cause of cancer death in the United States for both men and
women, and as such, represents a tremendous burden on the healthcare system. Survival
rates have remained relatively unchanged over the past forty years, yet we seem to be on
the verge of a paradigm shift as a result of advances in early screening, diagnosis and
better treatment modalities. Lung cancer is different from all other cancers in that 90% of
lung cancer cases can be attributed to the conscious behavioral risk factor of smoking,
either currently or previously engaged in by the patient. Funding and research has been
limited in terms of identifying the unique characteristics and needs of these patients, their
physicians and their caregivers. Ifsurvival rates improve dramatically, these patients will
be managed chronically rather than acutely in the near future. When this occurs, a lung
cancer treatment model for the future must be developed in order to more successfully
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prepare the market place for adapting to these unique patients and their providers who
will be operating in a chronic rather than acute care environment. Prior to the
development of such a model, the need exists to first develop a comprehensive
information map identifying knowledge and knowledge gaps with regards to these
patients and providers and their healthcare interactions and individualized needs.
Productive patient provider interactions are critical for successful chronic disease
management, and therefore several questions must be answered as they relate to treating
lung cancer in a more chronic versus acute environment.
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INTRODUCTION
Lung cancer represents only 13% of all new cancer diagnoses, yet it is the leading
cause of cancer death in the US for both men and women, accounting for almost 30% of
all cancer deaths (Lung Cancer Alliance, pI). Five year survival rates for lung cancer are
extraordinarily low, at less than fifteen percent, due to the fact that very few cases are
diagnosed at an early stage, local disease, with no lymph node involvement. Almost 70%
of all new lung cancers are diagnosed at very late stages of the disease, stage IIIb or stage
IV, and sutvival rates today are not dramatically different than they were in the early
1970's despite increases in survival rates for most other major cancers (Lung Cancer
Alliance, pI). The number of deaths each year from breast cancer, prostate cancer, colon
cancer, liver cancer, kidney cancer and melanoma combined will not surpass the number
of deaths each year from lung cancer (Lung Cancer Alliance, pI).
The medical costs alone for lung cancer are almost $5 billion annually (Lungusa,
p2). The American Cancer Society (2006) estimated that there would be 174,470 new
cases of lung cancer diagnosed and that there would be 162,460 lung cancer related
deaths last year. As with most cancers, there is a tremendous disparity with regards to
lung cancer diagnoses, with a disproportionate impact on minorities and those with a
lower socioeconomic status. African American men are 500/0 more likely than white men
to develop lung cancer. The incidence rate of lung cancer is equal for African American
women and white women, although the rates of smoking are much lower in the former
group (American Cancer Society, 2006). African Americans have both increased
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incidence rates as well as lower survival rates regardless of the stage in which diagnosis
is made, making the disparity for this group even more pronounced (NCI, 2004).
Prevention and early detection are key to reducing costs and the burden of illness.
Twice as many women will die from lung cancer compared to breast cancer, and three
times as many men will die from lung cancer compared to prostate cancer, and yet there
are currently no screening guidelines from the American Cancer Society related to early
detection of lung cancer in asymptomatic individuals (Lung Cancer Alliance, pI). The
fact that five year survival rates increase to almost 500/0 when a diagnosis is made early,
gives a strong push towards developing new screening tests, molecular markers, and
genetic breakthroughs to improve early detection as well as surgical or treatment
expectations for these patients. These advances, if successful, are likely to make early
diagnosis and more effective treatments a reality in the near future.
Molecular and cellular epidemiological research has focused on improving our
ability to understand the histologic changes that take place over the course of time,
leading from a normal healthy bronchial pathway to a malignant lung cancer cell. These
efforts are aimed at predicting not only which agents will cause cancer and the sequence
of events that will take place morphologically, but at identifying which patients are
genetically more predisposed to developing lung cancer in the presence or absence of
those identified agents and causal factors (Alberg, 2005). Fifteen years ago, the Early
Lung Cancer Action Project assessed the impact of an early diagnosis in smokers who
underwent annual spiral computed tomography - CT screening (Henschke, CI et ai,
1999). They found that 800/0 of patients diagnosed with lung cancer following annual CT
screening had early stage I cancer (Henschke, CI., et ai, 2004). Later follow up studies
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with these patients (Henschke, CI., et al2006) found that those who were diagnosed with
stage I cancer, had improved ten year survival rates that were as high as 88%; and that
all patients diagnosed with lung cancer, regardless of tumor stage, had a ten year survival
rate of approximately 80%. Based on the screening specificity seen in this trial with high
risk yet asymptomatic individuals, which was equal to or better than the specificity for
breast cancer screening via mammography (Henschke, CI., et a12006), it still remains
controversial as to why CT screening at less than $200 per person is not part of a routine
guideline. This remains a possibility in the near future that could have profound
implications for patients, physicians and third party payers.
New chemotherapy agents, along with the addition of targeted agents, have
already significantly improved median survival time and both one and two year survival
times (Molina, 2006). Further efforts that are successful in preventing lung cancer,
detecting lung cancer earlier or providing treatments that offer better outcomes, could
help change the way we view and treat lung cancer, which today is as an aggressive,
acute disease with a high mortality rate, shifting it towards a more chronically managed
condition that patients may live with for decades.
Due to the overwhelming mortality rates from lung cancer and possibly due to the
stigma associated with the disease, there has not been a tremendous amount of
information, research, and support developed for this particular group of cancer patients,
their caregivers or their physicians. Over 75% of physicians felt that if the stigma of lung
cancer being a self inflicted disease was not present, more patients would seek medical
information and treatment (LungCancer.org, p 2). A simple internet search revealed
twenty times more information readily available for breast cancer patients compared to
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lung cancer patients. If patients are to playa more prominent role in the management of
their disease, then we have to know more about what types of information they are asking
for and what types of information they need in order to improve the patient / provider
interaction in a chronic treatment setting. If gaps can be readily identified then a research
agenda can be developed outlining areas most in need of funding.
From 1999 to 2004, Congressional funding at the Department of Defense for
breast cancer was almost $1.7 billion compared to $33 million for lung cancer over that
same time frame. Over $200 million was allocated to the Center for Disease control in
support of breast cancer research in 2005, while there was zero funding allocated to this
group for lung cancer research that same year (Lung Cancer Alliance, pI). In 2004,
$13,953 was spent on research for every breast cancer death versus $1,723 for every lung
cancer death (LungCancer.org, p 3). Despite the fact that lung cancer remains the leading
cause of cancer death, the amount of funding spent on research broken out per patient
death provides further evidence that there has been very little attention devoted to
learning about this particular group of cancer patients.
Mapping what we do know and identifying gaps with regards to these patients is
important for several reasons. Of the new lung cancer patients diagnosed each year,
35%-40% are current smokers, 50% are former smokers and only 10% -15% are never
smokers (Lung Cancer Alliance, pI). Understanding more about the treatment
interactions and information needs of these patients is important due to the fact that lung
cancer patients may be inherently different from other cancer patients in that the majority
of lung patients engaged in smoking behavior, which is strongly associated with the
development of the disease. This could have a profound impact with regards to the
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potential long term interactions they may need to have with their oncologists and their
treatment teams.
Retrospective and prospective studies throughout the 1950' s began to report on
the association between cigarette smoking and lung cancer. The 1964 Surgeon General's
Report definitively concluded that smoking caused lung cancer (US Dept of Health
Education and Welfare, 1964). And yet despite all the awareness of smoking related
health risks, an estimated 45 million Americans are current smokers (American Cancer
Society, p 36). The fact that the majority of lung cancer patients engage in behavior
known to cause cancer, and that they subsequently face the stigma society attributes to
smokers, may indicate a marked difference in their health literacy as well as their health
beliefs, compared to other cancer patients, which will in turn impact their resource needs
as they move through the medical system. Additionally, the treating physicians as well as
caregivers may respond differently to these cancer patients and their disease management
needs.
Currently most lung cancer patients can be characterized as having an acute
illness due to the severity and mortality associated with most lung cancer diagnoses.
There may not be enough time in the treatment plan for patients to become very
knowledgeable, aware and involved in their particular treatment plan. Conversely,
patients with any chronic condition are generally encouraged to become more involved
and more informed with regards their health care, their disease, their treatment options
and their disease management.
In response to a quality report from the Institute of Medicine, Wagner et aI,
(2001) developed a chronic care illness model that served as a framework for
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understanding system changes necessary to provide quality chronic care. While their
model focuses on chronic care in the primary health care setting, the physical, mental and
social challenges they identify for patients and caregivers are arguably applicable in any
setting. Ultimately Wagner et ai, (2001) identify six "essential elements" overlapping
the community, the healthcare system and the provider organization that must work
together in order for quality chronic care to be delivered effectively. They identified the
need for 1) linkages to community based resources, 2) appropriate culture within an
organization that supports and rewards good chronic care, 3) self management support
with the patient as an active participant, 4) adequate delivery systems and practice teams,
5) evidence based decision support, and 6) clinical information systems to support and
evaluate decision making (p 69). As supported by Wagner et ai, (2001) and outlined in
the Institute of Medicine's Quality report, quality is likely to improve if the interaction
between the patient and the treatment team can become more productive.
Bodenheimer, Wagner and Grumbach (2002) assess that medical professionals
must work to help patients and caregivers develop the skills as well as the motivation and
confidence to selfmanage, set goals and follow up appropriately_ Oncologists who treat
lung cancer patients must have a clear understanding of their potentially unique patient
characteristics if they are to work in a collaborative and productive treatment
environment. Based on Wagner's (2001) chronic care model, four components are
critical for the thoracic treatment team to optimize during provider patient interactions:
garnering patient perspective regarding the course and management of the illness,
assisting the patient in goal setting and problem solving, applying clinical and behavioral
interventions aimed at reducing complications and improving well being and finally to

6

ensure continuous follow up. It is unclear at this point as to how prepared oncologists are
to organize and coordinate these types of interactions specifically for their patients
diagnosed and treated for lung cancer.
An essential question then becomes, what do we know and what do we need to

know in order to successfully anticipate and meet lung cancer patients' needs in the
chronic care setting? In order to better anticipate and meet the needs of these patients in
the future, we must be able to determine what information patients need now and what
questions they are asking now, as well as how they view their disease and make treatment
decisions. We also need to understand what is known about how physicians treating
these patients are able to anticipate and meet their needs and what challenges they must
overcome in the future in order to do so in the chronic care setting. To do so we need a
comprehensive model of the lung cancer of the future which incorporates what is known
about cancer management from other more treatable cancers as well as what is known
about the management of chronic diseases developed from the primary care setting.
With both breast and prostate cancer, there has been a tremendous increase in
patient awareness regarding screening guidelines, symptom development and treatment
considerations, as well as an increase in the patients' self management of those disease
states. In order for this to occur with lung cancer, we must better understand what
commonalities and differences they may have with other patients who manage serious,
chronic conditions for five to ten years following diagnosis as well as identify a research
agenda to fill in gaps in our informational market analysis.
We are on the verge of a paradigm shift with regards to the treatment model for
lung cancer. The final step is to develop a comprehensive model that integrates what is
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known from other cancers and adapt it specifically to lung cancer and the unique needs of
those patients and their treating physicians.
This project will encompass two main objectives. The first objective will be to
complete an integrative mapping of the literature and information available regarding
lung cancer patient characteristics as they relate to: 1) current lung cancer diagnosis and
treatment considerations, obstacles and barriers, 2) lung cancer patients' health beliefs,
therapy goals, treatment needs, and preferences as they relate to quality of life and well
being, 3) availability and operability of lung cancer patients' support networks and
caregiver needs, 4) current barriers and obstacles faced by these patients, including the
stigma associated with being a smoker, and 5) identification of a future research agenda
necessary to fill in all the knowledge gaps that would currently prevent the successful
disease state management of lung cancer as a chronic condition as outlined in the chronic
care model of disease management specifically as it relates to the physician-patient
interaction. The integrative mapping of the relevant literature will in fact be a case study
or market analysis of this patient population. In mapping what we know about the
characteristics of lung cancer patients, their decision making, and their information needs,
as well as their perceptions of their physicians and caregivers, I will develop several
hypotheses regarding how we can better anticipate and meet the needs of this patient
group as they relate to the chronic care model of illness. Additionally, this integrative
knowledge mapping should elucidate several gaps in the literature regarding the specific
health drivers related to this particular group of patients.
The second objective will be to develop a theoretical model from the patient
perspective that addresses both internal and external factors related to lung cancer
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patients becoming active, motivated and engaged participants in their chronic health care
management. This model will incorporate what is known about successful chronic care
patient interactions and incorporate specific influences that may face those patients
diagnosed with lung cancer.
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rvtETHODS
The first objective was to identify literature on the evidence and gaps with regards
to our knowledge surrounding 1) the decision making process and health beliefs relating
to lung cancer patients, their information needs and factors relating to their ultimate
treatment decisions, 2) barriers relating to diagnosis, treatment and subsequent behavior
interventions for lung cancer patients who are primarily smokers, 3) interventions and
goals of therapy that improve patient care and / or outcomes for lung cancer patients
diagnosed at both early and late stages of lung cancer, 4) tools and support services
available to help patients become more informed, active participants in their care choices,
and 5) information needed by clinicians to better coordinate and anticipate the care needs
of lung cancer patients for longer periods of time.
This research also identified where there was congruence with regards to
physician perception of patient related goals and preferences versus actual patient goals
and preferences, as well as the barriers faced in following through with recommended
treatment protocols. Following this review, a knowledge map was developed that will
later be useful in the knowledge transfer chain to providers, patients and health systems
via the Chronic Care Model as well as in the development of a future research agenda.
Knowledge mapping has been supported and developed over the last ten years by
numerous health agencies, including the World Health Organization, and has been useful
at the institutional level, the community level and the policy level (Ebener, et aI, 2006).
Prostate cancer researchers at Dana Farber Cancer Institute in Boston, Massachussets,
were successful in developing a knowledge map identifying the multiple domains of
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inequality as well as their interactions and relative contributions (Gilligan, 2005).
Through their development of a knowledge map, they were able to identify where there
was inequality, the overall relevance of that inequality, as well as the subsequent
identification ofa targeted research agenda. Alborz, McNally and Glendinning (2005)
were successful in mapping the issues faced by people with learning disabilities as they
related to healthcare access. The result of their mapping process was a modified access
to care model that was patient specific for those with learning disabilities. Again, the
mapping exercise allowed them to identify research gaps at both the macro and the micro
level resulting in the identification of several strategies to overcome specific barriers.
For this project, several data sources were identified and included bibliographic
databases, organizational websites and library catalogues. Literature reviews were
conducted using the following databases: Medline, CINHAL, PsychInfo, PubMed, and
Cancer Lit. Only articles published in English were included in the review. Thesaurus
terms were initially identified and searched in an integrative approach to identify the
literature that pertains to the following research questions: ''what do we know about lung
cancer patients, what do we know about how they make decisions, what do we know
about their health beliefs, what do we know about their support systems, what do we
know about their information needs as well as those of their caregiver networks, what do
we know about their decision making and preferences regarding different therapy
options, what questions are they asking now and what questions might they be asking in
the future, and what do we know about how they communicate with their physicians or
how they would like to communicate with their physicians in the future?"
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The development of a search strategy was an iterative process that involved the
following initial search and mapping of key terms followed by sequential searching based
on the findings or lack thereof The following search terms were systematically reviewed
both individually and combined: lung cancer, epidemiology, statistics, descriptive
statistics, decision making, quality of life, health screening, cancer screening, health
beliefs, smokers, non-smokers, smoking cessation, patient attitudes, patient navigators,
patient expectations, health behavior, health promotion, health services accessibility,
preventive health care, risk factors, diagnosis, symptoms, decision aids, decision support
techniques, caregiver networks, barriers to care, barriers to access, chemotherapy,
palliative care, patient education, attitude towards health, oncologists perceptions,
adapting to cancer diagnosis, stigma, unrealistic optimism, information needs,
information seeking, doctor-patient communication, therapy goals, follow up, and goal
setting.
Abstracts were then retrieved and reviewed for relevance. Original articles were
then retrieved and grouped according to topic. References in each article were then hand
searched to determine whether they should be included or to determine whether they led
to new search terms to be used in the process. Free text searching also took place to
identify any gaps in the search process. Research papers identified were then cross
referenced for similar papers and papers citing the work in question.
Quantitative and qualitative studies were included in the research review. Studies
that involved lung cancer patients and patients at risk for lung cancer were the primary
target during this review. However there was a need to include studies that involved
cancer patients in general or patients facing end of life decisions since they provided
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additional insight into the development of the model. The goal was to identify the
population at risk, those diagnosed with lung cancer or those at risk for being diagnosed
with lung cancer, and then to find out what information was available about those
patients that mayor may not differentiate them from other cancer patients based on the
fact that this is the singular cancer that arises primarily as a result of patient behavior
deemed to be risky and self imposed. Additionally the goal was to assess the gaps in the
literature regarding the care and needs specifically of lung cancer patients that need to be
addressed in order for the model of care to move successfully from one of acute care to
chronic care.
Issues and concepts were identified that related to health beliefs, decision support,
access to care, support networks, stigma, physician bias, and patient preferences, fears
and misperceptions regarding the quality or outcome of various care options. Articles
were included on smokers' attitudes towards health and risky behaviors, even though
many of those articles did not include patients diagnosed with lung cancer. The rationale
for this was that this patient population might have an unrealistic perception regarding the
risk of smoking and therefore may have an unrealistic perception regarding the benefit of
early diagnosis and various treatment options once they are potentially diagnosed with
lung cancer.
The literature searching was both an integrative and an iterative process that built
upon itself based on what was discovered. A knowledge mapping framework was then
developed that encompassed directional arrows representing hypothesized relationships
based on our knowledge from other cancer patients and incorporating what was actually
found regarding lung cancer patients specifically.
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Rather than using a reference manager database, the entire search file was saved
on the MUSe library search engine so that it could be continually evaluated for
continuity, directional growth and additions to the literature over time.
There are several limitations with this method of mapping. A limited number of
studies specific to patients with lung cancer were identified in the literature review and
there may be data that was not included or identified during the search process.
Numerous studies were identified that provided information on cancer patients' beliefs
and needs, and while those studies included lung cancer patients, their specific
information was not usually stratified based on tumor type, tumor stage, prognosis or
smoking status. The majority of studies that were reviewed had a small sample size of
lung cancer patients, and usually included patients with advanced disease and poor
prognosis. There were very few studies addressing lung cancer patients diagnosed early,
presenting with a much better prognosis, who may have somewhat different attitudes
towards future health decisions. Another limitation of this type of research is that based
on the stigma related to lung cancer, a number of patients have not been identified as
smokers, or have failed to acknowledge the role their behavior had in the development of
their disease and often have failed to be forthcoming regarding their true behaviors or
their expectations regarding their treatment methods, needs or outcomes. Given the fact
that lung cancer survival rates are so low, many patients may not have been told of their
true prognosis, many have not accepted their true prognosis and or many may not have
actually had the time to make health behavior changes prior to their final mortality related
outcome. However, the decision making process in this group of patients, regardless of
whether it is based on a realistic expectation of the outcome, is very relevant given that
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they are in fact making health care decisions in some cases without appropriate
knowledge or true informed consent.
Studies were not given a quality rating, as has been the case in other research
using literature reviews, but were used to develop the mapping concepts and assess
whether there is enough information to make a determination regarding a knowledge base
versus a gap. Any data available was deemed relevant in developing the knowledge map,
even if that ultimately represented a portion of the map that was more representative of a
knowledge gap or an area deserving of further research and exploration. This created the
opportunity to develop hypotheses for further testing. The quantity of the data for any
given subject heading was ultimately helpful in determining whether there was in fact a
knowledge base or a knowledge gap that should be further examined.
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RESULTS
The mapping process took place in two stages, the first of which occurred
simultaneously with the information review. The first stage of knowledge mapping
involved the development of the mapping domains along with a visual representation of
their interrelationships. Initially several domains were identified and mapped on a white
board. The starting point began with lung cancer patient characteristics and health beliefs
specific to people who were current or former smokers. During the search for
information, as new domains began to emerge they were added to the map.
Upon checking the references in each article identified, new domains were often
identified if they represented a knowledge base in another cancer type or another disease
type even if there was not data representative of what was known in lung cancer. The
identification of these domains then in turn led to the development of additional search
criteria and subsequently additional mapping domains.
Often the references in an article that pertained to another type of cancer were
helpful in developing a mapping domain even if that domain ultimately represented a
knowledge gap with regards to lung cancer patients. Reference checking was also helpful
in identifying articles that did not initially appear under a specific lung cancer patient
search but that included lung patient perspectives on topics such as communicating
prognosis or decision making. This data was often embedded in a study dealing with
numerous types of cancer patients.
The second part of the mapping involved synthesizing the information for each
given domain and developing an overall summary for each portion of the map. Initially
articles were read for content and a summary paragraph of key learning was written for
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each article. Article summaries were grouped and an overall summary was developed for
each map domain. Map domains were ultimately characterized based on whether there
was clear evidence, conflicting evidence or no evidence with regards to each topic. After
information was synthesized, articles were numbered and counted based on whether or
not they contributed to the overall information in one or more map domains. This
information is depicted in table 1. Numerous articles contributed information to more
than one map domain, which accounts for the fact that articles are referenced more than
once in the table.
Many papers represented information derived from a very small sample size, and
while the papers themselves may not have been relevant, they were helpful in developing
many of the mapping concepts that are still open for future research and development.
Ultimately 141 studies were included based on the value of the data provided to enhance
the development of a knowledge map and subsequent model development. Additionally,
studies were included that provided insight into patient decision making based on their
health status or their health behaviors leading up to a lung cancer diagnosis, which
primarily included those dealing with smokers and risk, optimism or cessation
interventions. Studies were also included that were literature reviews themselves, and in
those cases, all of the articles were not reviewed separately if the overall conclusions
could be ascertained from the primary review.
The only texts that were excluded involved studies relating to factors regarding
patient care or treatment outcomes that were outside the realm of individual patient
decision making, beliefs or quality of life, such as those relating to improvements in
genomics research, tumor staging, and treatment with investigational drug therapy. It
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was assumed that these factors were more relevant to changes in actual treatment
innovations, and they represented therapy related outcomes rather than patient choices,
decision making, self management, QOL interventions, or information and
communication needs. Additionally specific pharmaceutical studies related to drug
efficacy were excluded because they provided little information regarding patient
motivation or choice with the exception of studies that specifically addressed patient
related choices based on quality of life measures when deciding between therapy options.
The following summaries are representative of the information reviewed for each
mapping domain that ultimately guided in understanding what we know about the
specific characteristics of lung cancer patients with regards to how they make decisions
regarding the management of their disease:
Health Beliefs I Smokers
In developing a clear understanding of how to manage lung cancer patients in a
chronic care setting, it is important to understand their health beliefs may be different
than those of other cancer patients, and as such, they may need to be managed with
different considerations. For years the detrimental effects of smoking have been well
documented and publicized. Since the majority of patients with lung cancer have
engaged in a behavior known to cause such cancer, their perception of risk and optimism
may be different regarding health care, risks and benefits and medical decision making.
Optimism and Risk
Numerous studies show that smokers tend to be overly optimistic regarding their
chance of developing a smoking related illness such as lung cancer as well as the
possibility of cure in the event they do develop cancer. Smokers tend to attribute lung
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cancer to a number of other factors outside of cigarette smoking and greatly
underestimate their actual risk of developing lung cancer (Brownson, 1992; Dias, 2006;
Dillard, 2006; Donovan, 2006; Dowding, 2006; Hay, 2005; Ma, 2002; Dncken, 2005;
Salander, 2006; Silvestri, 2006; and Weinstein, 2005). Additionally smokers tend to
overestimate the survivability of lung cancer and have false optimism about the cure rates
(Dillard, 2006).
This false optimism seen by smokers is also demonstrated at times by patients
with lung cancer. Like smokers without cancer, lung cancer patients also overestimate
the survivability (Weeks, 1998) and may also fail to recognize the benefits of quitting
smoking even after being diagnosed with lung cancer. Studies have shown that the
majority of lung cancer patients believed that lung cancer was curable when they were
diagnosed, and less than 10% of those patients knew that their life expectancy was less
than one year (Malin, 2006). This is a very different thought process than what is seen
with other at risk cancer patients, such as with those at risk for breast cancer, who are
often overly pessimistic and think their prognosis is much worse than expected (Lipkus,
2001).
This misperception or denial of risk and false optimism seen in smokers and also
in lung cancer patients may be particularly important for physicians to understand as they
are trying to communicate accurate risks and expected outcomes of various therapy
choices so they can work jointly with patients to play an active role in deciding how to
manage disease (Cykert, 2004; and The, 2000). It is also important in thinking forward
regarding future health behavior interventions that if patients in fact end up surviving
lung cancer for longer periods of time, then their false optimism may seem justified in
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their mind. This might make it difficult for physicians to convince them of the
importance of preventing future health complications or modify health behavior.
Stigma
Several studies and surveys have reported on and hypothesized about the role that
stigma as it relates to smoking and its cause and effect relationship with lung cancer may
play with regards to low funding levels for lung cancer research. Additionally, the stigma
that many lung cancer patients feel from community, friends, family and health care
providers may also playa role in their decision to seek medical help, which in tum can
delay diagnosis and treatment (Chapple, 2004). Studies have found that smokers often
feel unworthy of care (Street, 2004 and Corner 2005) and are ashamed and embarrassed
to tell people of their smoking related illness. This in tum could lead to a decreased use
of community based resources aimed at support, behavioral interventions, and outreach.
Additionally, the stigma faced by some may in fact prevent them from recognizing or
accepting the role smoking played in the development of their lung cancer (Chapple,
2004). This inability to look at cause and effect may impact patients' future decisions or
attempts to try to quit smoking as many lung cancer patients never accept the fact that
smoking behavior was related to their lung cancer diagnosis.
Access
Several studies indicate that socioeconomic status, insurance status and geography
playa role in decreasing patients' access to care, resulting in poorer outcomes (Campbell,
2001; Earle, 2002; Hall, 2004; and Silverstein, 2002). This may account for some of the
disparities in survival seen with African American patients (Ferguson, 2003; Holzman,
1995; and McDavid, 2003). However, other data suggests that when access was
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universal, there were no differences in outcomes (Mulligan, 2006). One factor that has
not been studied that must be addressed is service capacity as it relates to access. If lung
cancer patients have increased survival rates, there will be a tremendous increase in the
number of patients being managed in the system. It is unclear what impact this will have
on physicians, nursing staff and the multidisciplinary treatment team. If lung cancer
survival increased by twelve months, over 150,000 patients would remain in the system
in the first year alone. These patients would need three or four follow up visits during
that year. Access might be limited based on the number of providers and support staff,
and lengthy delays in follow up care or in new patient visits could occur. Economic and
feasibility studies need to be done to see what changes must be made in the system in
order to meet access needs if there is an increase in demand.
Diagnosis and Treatment Delay
Lung cancer patients as a group have a much higher likelihood of individuals
delaying diagnosis or treatment versus those with other cancers. While there is limited
data on both patient as well as physician delay, preliminary evidence suggests that the
majority of patients delay seeking help by more than three months (Salomaa, 2005). As
discussed above, several studies have reported on the role that stigma and feelings of
guilt that led to patients' feeling unworthy of care resulted in delays in seeking medical
attention, thus delaying diagnosis and treatment. Additionally, numerous studies report a
general lack of understanding and awareness regarding the early warning symptoms of
lung cancer that should in fact prompt patients' to seek help (Comer, 2005 and
Levealahti, 2006). While there is almost universal awareness regarding breast self exams
and the need to get suspicious changes or lumps checked by a physician, it has been
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estimated that more than half of smokers fail to identify symptoms of lung cancer
(O'Conaill,2005). Patients in several studies reported having symptoms for months or
years prior to the diagnosis of lung cancer, but often felt the symptoms weren't serious
enough to warrant medical care, were related to their other health comorbidities rather
than a new, more serious condition, or were simply part of getting older (Comer, 2005;
Comer, 2005; and Levealahti, 2006).
This represents a serious need for awareness campaigns that educate smokers
about the early signs and symptoms of lung cancer.
Disease Management / Treatment Decision Making
In order for any patient to be actively involved in the decisions regarding
treatment, they have to be well informed and have a clear understanding of the treatment,
the expectations or goals, the risks, side effects and alternatives. Studies have
documented wide variability in treatment choice among lung cancer patients based on
cure, response, toxicity, prognosis, and symptom relief (Hirose, 2005; Markman, 2006;
Matsuyama, 2006; Silverstri, 1998; and Skinn, 1994). Data suggests that most lung
cancer patients want a collaborative role in making treatment decisions (Davidson, 1999).
They also need specific information regarding details of the therapy, anticipated early and
later side effects, survival estimates, and symptom relief to make choices consistent with
their beliefs (Feldman-Stewart, 2004; Sorensen, 2004; and Weeks, 1998). However,
studies have shown that fewer than half of lung cancer patients being treated ever had a
discussion with their physician about therapy choices or about selecting therapy based on
side effect profiles (Dubey, 2005). Physician goals of therapy agreed with patient goals
of therapy only 50% of the time in one study (Chu, 2007), and other data suggests that
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fewer than 25% of patients would choose their same treatment again, indicating a lack of
clear communication and understanding between physician and patient (Krishnasamy,
2001; Quirt, 1997; and Silvestri, 1998).
Understanding how lung cancer patients make decisions is critical given their
health beliefs, risk assessments and often unrealistic optimism. A number of factors
including race, ethnicity, age, spirituality, coping skills, and familial support have been
identified as having an impact on lung cancer patients' treatment decision making process
(Lathan, 2006; Markman, 2006; Margolis, 2003; Sharf, 2005; Silvestri, 2003; Siminoff,
2006; and True, 2005). While their specific impact or role in decision making is not fully
known, physicians often failed to recognize them as being important factors to consider
when talking with patients about therapy options, and data suggests that treatment teams
failed to improve the quality of decision making versus that of individual physicians
(Kee, 2004).
Numerous studies have shown that decision aids are effective in helping lung
cancer patients increase their knowledge as well as make therapy choices that reflect their
true values and desires (Brundage, 1998, 2000, 2001; Fiset, 2000; and Leighl, 2004).
However, there is no clear standard as to the content that should be included and patients'
needs and comprehension skills vary widely. It has also proven difficult to include risk
assessments in an accurate manner given smokers' beliefs regarding risk versus non
smokers' beliefs regarding risks (Feldman-Stewart, 2004). There is data that suggests
that lung cancer patients are in fact willing to accept small benefits with big risks more so
than other patients (Cykert, 2004; Hirose, 2005; and Matsuyama, 2006). Physicians
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should be aware of the differences in risk perception among smokers, and thus most of
their lung cancer patients.
Communication
Since risk decisions can only be made with accurate information, physicians are
often at a loss as to how to communicate risk to lung cancer patients who, as a group
made up primarily of smokers, tend to make unrealistic risk assessments. There is little
information regarding communication needs and preferences with lung cancer patients
specifically, yet limited data suggests that patients who receive diagnosis and information
from a specialist are more likely to be clear on the disease specifics (Krishnasamy, 2001).
The fact that several studies showed wide disagreement with regards to patient and
physician stated therapy goals, actual therapy choices or expected prognosis shows that
this is an area for future research (Chu, 2007; Quirt, 1997; Sharf, 2005; Weeks, 1998; and
Yardley, 2001). Numerous studies exist with breast cancer patients regarding the
communication preferences regarding prognosis and therapy and data suggests this may
vary by tumor type (Hagerty, 2005). Studies need to be done with lung cancer patients
specifically.
Physicians must recognize that patients have attachment needs and that in order to
include them in the decision making process, they must establish a relationship and trust
(Cykert, 2004) and in some cases starting that communication prior to the first patient
visit was viewed as positive (Quinn, 2007). This may be particularly true when dealing
with African American patients who reported lower levels of trust based on their
perception of poor physician communication (Gordon, 2006).

Patients' desires for

increased communication or information may in fact be an increased need for relationship
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building and further communication on the part of the physician (Salandar, 2005 and
Sharf, 2005). Physician communication style was seen as one of the strongest predictors
of patient participation during the consultation (Street, 2005). Physicians who used more
supportive and partnership building communication styles had patients with increased
levels of participation (Street, 2006). Whether this type of communication style is widely
used by oncologists is currently unknown.
Information
Lung cancer patients get their information from a variety of sources both formal
and informal, however the quality and completeness of that information is often low
(Mat suyama, 2006). However, patients often overrate the quality of the information they
receive from sources other than their physician (peterson, 2003). There is a lack of
information available that addresses survivability or treatment success (Donovan, 2006
and Matsuyama, 2006), and this is often the type of information patients ask for and need
in order to make informed choices. Additionally data suggests that much of the
information available needs to be written at lower reading level in order to be useful to
the majority of lung cancer patients (powers, 2006). Most data showed that lung cancer
patients wanted and needed detailed, specific information in order for them to participate
with a high level of involvement (Davidson, 1999 and Sorensen, 2004).
There was evidence that race may also playa role in the amount of information
lung cancer patients receive from their physician. Sometimes black patients received less
information from their physicians. It is unclear as to why this is the case, however it
could be related to the fact that black patients often participated less frequently and were
less likely to bring a companion with them during their consultation versus white lung
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cancer patients (Gordon, 2006). Limited data exists regarding the role race and ethnicity
play on the preferred information venue with cancer patients in general, with data from
one study suggestive of white patients preferring medical journals, telephone and internet
sources, Japanese patients preferring media and commercial sources of information, and
other Asian patients preferring personal communication with physicians, peers and social
groups (Kakai, 2003).
The internet was the most common source of information for lung cancer patients
outside their physician (peterson, 2003), however there are no studies measuring the
effectiveness of internet education in lung cancer. Lung cancer patients who used the
internet expressed strong interest in participating in clinical trials (Markman, 2005), and
smokers who used the internet expressed greater interest in quitting smoking (Stoddard,
2006).
It is important to recognize that lung cancer patients' information needs may
change over the course of their illness and their preferred method of communication may
change as well (Moore, 2006). Patients seemed to express interest and satisfaction using
e-mail and telephone calls for advice, information and follow up (Moore, 2004). Further
investigation into the information and resource needs of lung cancer patients is warranted
and should also try to illuminate further information regarding the specific needs of
different ethnic and minority groups.
Problem Solving
Patients managed in the chronic care setting must partner with their provider so
that can be actively involved in problem solving. There was no data available to
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determine lung cancer patients' preferences or abilities to problem solve in an acute or
chronic care environment.
Goal Setting
No data exists on how lung cancer patients and physicians work together to set
realistic goals related to patients' treatment, behavioral interventions and follow up plans.
Lung cancer patient advocacy groups were limited with their information on patient
expectations. Data showed that when breast cancer patients used a combination of
physical and psychological interventions, including goal setting, they were better able to
manage chronic pain (Robb, 2006). Patients in a general cancer population were most
likely to set rehabilitation goals to improve self care, leisure activities and productivity
(Watterson, 2004). These goals were rated as equally important to the patient. There is
also data suggesting that in the general cancer population, misdirected goal setting was
associated with increases in depression (Street, 2003).
There is clear need for further research involving lung cancer patients and their
ability to set and meet both short term and long term treatment, intervent.ional and follow
up goals. Additionally, studies to outline appropriate goals are necessary so that patients
can have a clear understanding of which goals might be realistic and appropriate for their
given care plan. Although hospice patients are in a terminal phase, it is possible that we
could learn from the body of evidence regarding how those patients, including lung
cancer patients, set goals with regards to physical, emotional or spiritual needs at the end
ofHfe and apply this information in a more chronic phase (pizzi, 2004).
Self Management
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There was limited information regarding how to help lung cancer patients take a
more active role in self managing their disease, their symptoms and their quality of life.
Numerous studies did show that patients who were directly involved in managing their
care had improved quality of life scores, and that those patients also exhibited a strong
awareness of resources, had strong self efficacy beliefs and lower anxiety or depression
versus other lung cancer patients (Boehmer, 2007; Downe-Wamboldt, 2006; and Maliski,
2003). Additionally, several studies found that patients using complementary or
alternative medicine were more likely to be involved in self management and considered
their use of those therapies as a positive step towards fighting cancer (F ouladbakhsh,
2005 and Molassiotis, 2006). There was conflicting evidence regarding how well
caregivers were able to assess a patient's ability to self manage, with some studies
showing that caregivers over rated patients' abilities while others showed that they
underestimated patients' abilities (Madison, 1995 and Porter, 2002).
This indicates a need for treatment teams to help patients understand all the
resources available, and to assess and treat depression and anxiety as quickly as possible
in order for the patient to optimize self management skills. Furthermore, the studies
represented here indicate a need for further research aimed at helping the physician assess
patients' abilities more accurately rather than using surrogate assessments from
caregivers. Further work needs to be done to detennine which types of interventions are
most helpful in increasing lung cancer patients self efficacy beliefs and coping skills.
Follow Up
There is a lack of general consensus on how to follow up with lung cancer
patients using evidence based guidelines that ensure quality care that is cost effective
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(Saunders, 2003). Studies indicate there is a need for patients to have access to the well
informed, multidisciplinary treatment teams, but no clear measure of how to do this
effectively. The follow-up expectations that are in place focus solely on follow up for
acute lung cancer, and there are not any specific recommendations for chronic care
management or coordination (Smith, 2003).
Several studies showed that patients were willing to follow up with the help of
nursing led clinics or interventions and that up to 20% of all follow up might be
appropriately led by nurses, particularly if the follow up involved physical or
psychological needs (Cox, 2006). Training and support needs have been preliminarily
outlined for these demanding roles and further implementation guidelines are necessary.
Lung cancer patients expressed satisfaction with nursing follow up services in person and
via telephone as they transitioned from active care to follow up care (Moore, 2006).
There is a clear need for more information regarding cost effective follow up care
that takes into account the comorbidities and health behavior interventions necessary for
lung cancer patients to lead longer, more productive lives. There is no clear cut method
for providing, developing or coordinating follow up care plans.
Ouality of life / Well being
Maintaining a good quality of life is important for all cancer patients, and health
related quality of life domains of importance differ by tumor type (Osoba, 2006) and may
prove to have inherent prognostic value (Maione, 2005). It is important to identify the
many needs of lung cancer patients and their support groups or caregivers, prior to the
start of therapy, as these patients present with greater psychological and physical burden
compared to most other cancers (Bozcuk, 2006 and Ko, 2003), and persistent smoking
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often decreases quality of life even further among this group of patients (Garces, 2006).
A review of the literature revealed that there is no clear cut evidence regarding who is
best qualified to lead, manage or coordinate behavioral interventions aimed at improving
well being and quality of life for lung cancer patients (Thompson, 2005). This
illuminates a need for research into whether patient navigators, thoracic nurse specialists
or another member of the multidisciplinary team should take on this responsibility_
Psychosocial
Lung cancer survivors may have more physical and psychosocial needs than other
cancer survivors (Schag, 1994), and yet they often feel that their psychosocial issues are
not being addressed by their provider, and this often leads to distress. These needs are
expressed by caregivers as well (Li, 2006). Social constraints among spouses including
denial, conflict, and criticism can lead to increased distress (Badr, 2006). Less than half
of lung cancer patients felt that their concerns had been discussed with their healthcare
team, and psychosocial issues were the ones most often overlooked (Hill, 2003).
Improving physicians' understanding of specific patient concerns as well as the addition
of psychosocial interventions may improve quality of life scores (Montazeri, 1998)
EmotionallPsychological
From a quality of life perspective, lung cancer patients exhibit some of the highest
levels of emotional and psychological distress of any cancer patient group (Li, 2006;
Lidstone, 2003; Walker, 2006; and Zabora, 2001). Feelings of anger may be more
prevalent among this group of cancer patients versus others. Interestingly, some studies
showed that this level of psychological distress was not correlated with a lack of family
support or religion as might be expected (Kuo, 2002). Younger patients seemed to
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experience greater levels of distress than older patients (Graves, 2007), and those patients
who used adaptive coping skills along with problem focused coping skills tended to
improve more so than those who used emotion focused coping strategies (Kuo, 2002 and
Walker, 2006). There was also a positive correlation between increased symptom distress
and increased emotional distress, underscoring the need to address all aspects of lung
cancer patients' physical and psychological concerns jointly (Montazeri, 2003).
Additionally, the fact that some types of coping skills work better than others, indicates a
need for physicians and support team members to be aware of which types of coping
skills patients might typically use versus those they may need to be taught.
Spiritual
Several studies have shown that for lung cancer patients, spirituality plays an
important role in both decision making as well as in quality of life, and in one study it
ranked second only behind oncologists' recommendations in helping patients make
critical decisions (Silvestri, 2003). However, the spiritual needs of patients and their
caregivers are often not taken into account by physicians (Murray, 2004). Spirituality
had a positive effect on physical and psychological quality of life for lung cancer patients
(Meraviglia, 2004) and led to less depression in spouses who used moderate religious
coping skills with patients (Abernethy, 2002). Physicians need to be aware that
spirituality and coping skills often differ by ethnicity and race and that this may lead
patients to make different choices than recommended or expected (True, 2005). One
study compared lung cancer patients with heart failure patients and found spiritual needs
to be different based on the different disease trajectories (Murray, 2002). This could raise
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future questions regarding the spiritual needs of lung cancer patients if it becomes a more
chronic condition with a disease trajectory more similar to cardiac failure.
Depression!Anxiety
Studies estimate that as many as one third to half of all lung cancer patients
experience depression during the course of their illness and this rate may be higher than
for most other cancer patients (Carlsen, 2005; Krishnasamy, 2001; Sarna, 2005; and
Walker, 2006). Often this depression goes undiagnosed by the treating oncologist.
Studies show there are also discrepancies in physician and patient reported levels of
anxiety (Krishnasamy, 2001). Recognizing and treating depression early in this group of
patients has been successful (Carlsen, 2005), and it is critical for chronic care
management due to the relationship between depression and quality of life, symptom
management and the patients' ability to participate successfully in health behavior
interventions (Fox, 2006). Lung cancer patients who are depressed have decreased
quality of life scores, report increased levels of fatigue as well as increased likelihood of
smoking relapse (Walker, 2004). While depression itselfwas not related to decreased
survival rates, those patients who used depressive coping skills did have decreased
survival (Faller, 2004). Additionally, studies of patients with chronic diseases have
shown that in patients with chronic disease the addition of depression resulted in a
doubling of the use of acute services (Himelhoch, 2004). Oncologists need to screen,
identify and treat depression early in all their lung cancer patients.
Support Networks / Caregivers
The support networks available to cancer patients playa vital role in helping those
patients cope with and manage their disease. There is very little information regarding
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the specific supportive care needs of lung cancer patients or how their support networks
help meet those needs. There is data to suggest that lung cancer patients compared with
other cancer patients have a greater number of unmet psychological, physical and daily
needs, many of which are not recognized by the caregivers (Broberger, 2005; Lidstone,
2003; and Madison, 1995). This may be related to the fact that they present with more
comorbidities, a greater likelihood of depression and possibly fail to seek support due to
the stigma they feel as a result of their disease. Limited information suggests that fewer
than half of lung cancer patients were able to get the help they needed from community
based services, while physicians often underestimate the available support for patients
(Krishnasamy, 2001 and Sharpe, 2005).
Caregivers of lung cancer patients often take on a great burden in caring for these
patients, and they are also at risk for decreased quality of life and depression (DowneWamboldt, 2006; Sarna, 2006; and Pinquart, 2005). Studies have shown that family
members often feel the impact of the patient's fatigue even more so than the patient
(Hamilton, 2001). Reducing caregiver burden was shown to be more important than
increasing social services in at least one study (Kim, 2005). Interventions that aided the
caregiver in learning about the disease, treatments, and problem solving or coping skills
reduced their burden (Abernethy, 2002). Further information needs to be gained
regarding the coping skills that could be useful in reducing caregiver depression and
quality of life so that they can he better positioned to help the lung cancer patient.
Health Behavior Interventions
Numerous health behavior interventions have been identified that enable cancer
survivors to live healthy lives with improved quality ofHfe scores (Hately, 2003; Ryan,
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1996; andThompson, 2005). However, most cancer patients don't receive this guidance
from their oncologist. One review found that fewer than 20010 of oncologists give their
patients guidance on health behavior interventions aimed at improving health and
decreasing risk of other progressive diseases (Denmark-Wahnefried, 2005). These types
of interventions will apply more frequently to lung cancer patients in the future should
their life expectancy increase and they become managed like patients with other chronic
conditions. This is particularly true for lung cancer patients because they tend to have
decreased quality of life scores versus other cancer patients along with a heavier burden
of illness (Sugimura, 2006). The impact of comorbid conditions on lung cancer
survivability is currently unknown. This represents a change in the types of health
concerns oncologists will need to manage with their lung cancer survivors in the future.
In patients with lung cancer, there is no clear data on who is most qualified to coordinate
or lead these jnterventions from the multidisciplinary team, although there are several
studies indicating that many health behavior interventions can be and should be led by
qualified nurses.
Smoking Cessation
There is a wealth of published information on smoking cessation, behavioral
interventions, and relapse in the general population, which won't be discussed in detail
here. Given the fact that 90010 of lung cancer patients are current or former smokers,
smoking cessation in this specific group of patients is particularly important. Many
oncologists agree that given the short prognosis, smoking cessation is often not a primary
concern even though smoking cessation improved performance status in at least one
group of lung cancer patients (Baser, 2006). One study showed that only 25% of lung
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cancer patients were told by their physician that they needed to quit smoking following a
diagnosis of lung cancer (Evangelista, 2003). Various studies show that a number of lung
cancer patients who are smoking at the time of diagnosis continue smoking during or
after treatment (Cox, 2002; and Schnoll, 2003).
Relapse rates among quitters was also high, with as many as 40% of patients
relapsing after one year and 60% relapsing after two years (Walker, 2004). Relapse
seems to occur most frequently after only two months (Walker, 2004, 2006), and most
often by those who failed to admit the role tobacco played in the development of their
illness (Schnoll, 2002, 2004). Relapse was also high among patients who waited until
surgery to quit smoking (Walker, 2004, 2006) as well as among patients whose family
members continued to smoke.
There is little data regarding which types of programs are most effective for lung
cancer patients, but data points towards a combination of behavioral conditioning and
reinforcement strategies (Schnoll, 2002). There is information that indicates that patients
who are most likely to decline smoking cessation interventions altogether include those
with fewer physical symptoms and those who are light smokers (Schnoll, 2004).
Regardless of the type of program, many physician led smoking interventions were not
effective, indicating a need for identifying effective smoking cessation programs led by
others (Gritz, 1993; Schnoll, 2003).
Given the totality of the health risks and the comorbidity associated with
smoking, in the chronic care setting smoking cessation will become more important for
those patients expecting to survive lung cancer for several years. As many smokers cling
to myths regarding the impact of smoking on health (Dillard, 2006), physicians must
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focus their efforts on getting patients to understand the benefits of smoking cessation as it
relates to lung cancer as well as other health conditions.
Physical Interventions
There is very limited data on the successful implementation of behavioral
interventions to increase physical activity with cancer patients in general and none were
found relating to lung cancer patients. Yet this is an important variable given the limited
evidence suggesting that lung cancer patients may have a higher number of physical
symptoms and concerns versus other cancer patients. Studies show women with lung
cancer may present with worse physical functioning than women with other cancers
(Doorenbos, 2006), and that lung cancer patients' physical mobility generally declines
after treatment. Data from the American Cancer Society is very limited and only
includes a recommendation that lung cancer survivors increase physical activity (Ashley,
2005). Limited information shows that interventions improving physical functioning in
other cancer patients improved quality of life (Smith, 1996) as well as patients' ability to
manage pain (Robb, 2006). This information needs to be determined in the lung cancer
population.
Alcohol/Nutrition
There is very limited data regarding behavioral interventions designed to improve
dietary habits and alcohol intake among cancer patients in general and even less
information specific to lung cancer patients. Given the short prognosis for lung cancer,
this has not been a concern for most oncologists. However, data suggests a correlation
between alcohol use and smoking, therefore information on patients' alcohol use is most
likely going to be an important factor during the management of lung cancer patients in
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the chronic care setting. Data from one study suggests that almost 60% of long term lung
cancer survivors continued their use of alcohol and that SO % of long term lung cancer
survivors were overweight five years post treatment (Evangelista, 2003). Data from the
American Cancer Society ifvery limited at best, recommending only that it is probably
beneficial for lung cancer survivors to maintain a healthy weight and to increase fruit and
vegetable intake (Ashley, 2005). There are no recommendations regarding how patients
should accomplish this, and yet there is data that nutritional status is often already
compromised when patients present with lung cancer diagnosis (Beach, 2001) and that
status worsens during treatment.
There is a need for understanding which behavioral interventions work as well as
a need to determine how to present these interventions and gain agreement from patients
regarding their impact and importance. Additionally, as family members often continue
to drink, there may be a need to target them along with the patient (Sarna, 2006).
Comorbidities
Numerous studies have reported on and identified the comorbidities associated
with lung cancer that are often attributed to smoking. Lung cancer patients have an
extremely high incidence of comorbidity, with almost 90010 of patients presenting with at
least one and 50% of patients presenting with three or more comorbid conditions
(Tammemagi,2004). The presence of comorbid conditions in lung cancer patients has
been shown to be predictive of lower health utility scores (1<0,2003; Sugimura, 2006).
While some studies have failed to show an association between comorbidity and survival,
others have shown that survival is adversely effected independent of treatment, thus
leaving it unclear as to the true impact comorbid conditions may have on long term

37

survival (Sugimura, 2006; Tammemagi, 2004). There is no data regarding the
management or follow up of these comorbid conditions in lung cancer patients and there
are no current recommendations.
Symptom Management
Symptom management and therapy side effect management is critical for all
cancer patients, however given the heavy burden of illness seen with lung cancer patients,
it is vital for physicians to understand the distress felt by their patients, along with an
understanding of their primary concerns (Dubey, 2005; Hsu, 2003; Lidstone, 2003).
Fatigue, pain and depression and breathlessness are the most common symptoms
experienced by lung cancer patients (Kiteley, 2006; Kuo, 2002; Lidstone, 2003), and
while there is often agreement between the patient and physician regarding symptoms
experienced (Basch, 2006), several studies showed that both physicians and caregivers or
family members often overrated or underrated lung cancer patients' symptoms
(Broberger, 2005; Lobchuk, 2006; Madison, 1995). Lung cancer patients often used
complementary or alternative medicine to control or alleviate symptoms and this varied
widely based on gender, age and geography (Fouladbakhsh, 2005; Wells, 2007). Patients
often learned of these methods through family, friends and other lung cancer patients.
The lack of data regarding symptom management once the patient is out of the acute
phase underscores the need for interventions for both patients and caregivers.
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DISCUSSION
A visual model representing the factors that could influence or could represent
what is necessary for a more active and informed lung cancer patient was developed (Fig
2). This model is adapted from and incorporates elements of Wagner's (2001) chronic
care model that specifically relate to the patient side of the physician - patient interaction.
Four key components detailed in Wagner's model that are necessary for an active,
informed patient participant in the chronic care setting serve as the core, central theme in
this model, and are critical in order for lung cancer patients to playa role in managing
their own chronic health care needs. These four themes can be thought of as internal in
the context that they relate to individual patients and their knowledge, how they process
that knowledge to make decisions, how they internally take responsibility for self
management, how they internalize quality of life measures as well as apply QOL
interventions, and how they accept responsibility for follow up care. The model itself
should be viewed as cyclical rather than static, in that during each stage of chronic care
management, or during new acute stages, the patient should be expected to go through the
same circle or thought process.
The outer portion of the circle represents the various external factors that may
influence or place strain on the patients in their attempt to play an active, informed role.
The factors include community communication and information transfer examples of
which are literacy levels of information, technology available to deliver and receive
information, venue of communication, and lack of prepared patient information.
Examples of community based barriers include geography, finances, physical limitations,
and service capacity. Examples of community support networks that need to be
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considered are the availability of caregivers, community support groups, outreach and
advocacy groups. Finally the community health beliefs that may exert influence on the
patient include stigma, anti-smoking legislation, and media influence.
Future research should focus not on the internal or the external components
individually, but should reflect the impact they may have with one another. For example,
it is difficult to assess appropriate follow up care plans without also assessing how lung
cancer patients want to communicate regarding follow up, how their support network can
assist them with follow up, and what barriers might exist that prevent them from actively
participating in their follow up plan on a routine basis.
This model represents the fact that in order to prepare the market place for a more
chronic version of lung cancer, numerous research questions must be addressed and
explored in order to develop an appropriate strategy that aids lung cancer patients in
becoming both informed and motivated to a level where they can actively participate in
their health care decisions over a prolonged period of time.
In this mapping exercise I have tried to address the following questions:
1)

what do we know about lung cancer patients' health beliefs and how
does that influence their decision making regarding treatment decisions
and quality of life

2)

what do we know about lung cancer patients' and their communication
and information preferences including both physician communication
and preferred information seeking methods and tools

3)

what do we know about lung cancer patient support systems both
internally and externally driven
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4)

what do we know about specific barriers faced by patients with lung
cancer with regards to managing their health needs
The interrelationship of these themes with the chronic care model has been

incorporated into the new model representing the dynamics that should be considered
when assessing lung cancer patients' readiness to participate in a productive chronic care
relationship with their oncologist. This patient oriented model represents the first step
towards developing a more extensive assessment of chronic care lung cancer treatment.
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CONCLUSION
This integrative research study has identified 23 individual factors that are known
to encompass the individual building blocks needed to move the management of lung
cancer from the current acute, terminal care mode towards a chronic care model. This
review indicates that much research needs to be done before we can begin to successfully
manage lung cancer as a chronic disease. In only three of the 23 areas do we have good
information related to lung cancer, and in no case is information at the level of
excellence. In three areas, there is good evidence in general cancer, but not specifically
for lung cancer, and in the remaining 17 areas there is inadequate or no evidence.
Given the current level of funding for lung cancer research, it is unlikely that we
will be able to gain evidence in the near future. Thus, the promises for long term survival
that are emerging from screening and treatment advances are unlikely to come to fruition
for patients under real practice conditions unless a major change in research funding for
lung cancer occurs soon. This study provides information on the building blocks needed
to move lung cancer care into the future. It is imperative that research on these building
blocks for future lung cancer care is recognized by leaders in the field and receive
attention and funding. Without this evidence we can not move forward in caring for lung
cancer patients.
In assessing the knowledge gaps or discrepancies identified in this knowledge
mapping exercise, two important areas to address that would have an immediate impact
on patients now and in the future are identified. There is clearly a need for better tools to
help improve communication regarding treatment options and goals so that there is
improved understanding at the patient level and improved agreement between patients
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and physicians regarding the actual expectations from therapy. Secondly the gap in
identifying and treating depression in this group of patients must be addressed to improve
quality of life in both the short term and the long term for acute and chronically treated
lung cancer patients.
In addition to the research gaps identified in the knowledge mapping exercise, the
next research need to be addressed in the future should involve a focus how physicians
treating lung cancer can prepare for more productive physician-patient interactions and
relationships. We must understand physician perceptions regarding their readiness to
participate in and manage lung cancer patients through a much more prolonged series of
productive physician patient interactions, as well as identifying their perceived barriers to
this type of interaction at the individual, institutional and system levels of care.
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Table 1
Domain Rating

Mapping Domains

References Included

Stigma

Chapple, Comer, Comer, Street (2004)

2

Access

Campbell, Earle, Ferguson, Hall, Holzman
McDavid, Mulligan, Silverstein, Street (2005)

o

Health Beliefs! Smokers
Optimism

Dillard,

Donov~

Hay, Malin, The, Weeks

2

Brownson, Cykert(2004), Dias, Dillard, Dowding, Hay,Ma,
Lipkus, Malin, Oncken, Salander (2006), Silvestri (2006)
Weinstein

2

Comer, Comer, Levealahti" O'Conaill,
Salomaa,Sharf

0

Bmndage 1998,2000, 2001, Ch~ Cykert 2003,2004,
Davidson, Dubey, Earle, Feldman, Fiset,Hirose, Kee,
Krishnasamy, Lathan, Leighl, Margolis,
Markman 2005, 2006 Matsuyama, Molassiotis,
Quirt, Sharf, Silvestri 1998, 2003, SiminoiJ, Skinn,
True, Weeks

0

Infonnation

Davidson, Donovan, Feldman, Gordon, Hagerty,
Kakai, Malin, Markman 2005, Matsuyama, Molassiotis,
Moore (2004, 2006, 2006), Peterson, Powers,
Sorensen, Stoddard,

0

Physician Communication

Chu, Cykert, 2004, Gordon, Hagerty,Krishnasamy, Leight,
Quinn, Quirt, SaIander 2005, Sharf, Street 2005, 2006,
Yardley, Weeks

1

Goal Setting

Pizzi, Robb, Smith (1996), Street (2003), Watterson

0

Self Management

Boehmer, Downe - Wamboldt, Lobchuk, Fouladbakhsh,
Madison, Maliski, Molassiotis Porter,

0

Risk

Diagnosis / Treatment Delay

Treatment Decisions /
Disease Management

o

Problem Solving
Follow Up

Cox (2006), Moore (2006), Saunders, Smith 2003

0

Comorbidity

Ko, Sugimura, Tammemagi,

0

QOL - Well Being

Bozcuk, Downe - Wamboldt, Garces, Ko, Maione,
Maliski, Osoba, Ryan, Thompson

0

Support Networks

Broberger, Chapple, Downe - Wamboldt, Hamilton, Kim,
Krisbnasamy Li, Lidstone, Lobchuk, Madison, Sharpe
Abernethy, Moore, Pinquart, Sarna 2006

Caregivers
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0

Side Effects /
Symptom Management

Basch, Broberger, Downe - Wamboldt, Dubey,
Fo~ Hsu, Kitely, Kuo, Lidstone, Lobchuk, Madison,
Molassiotis, Wells

0

Psychosocial QOL

Badr, Graves, Hill, Li, Montazeri (1998, 2003), Schag

0

Emotional

Kuo, Lidstone, Sarna 2006, Walker 2006, Zabora

0

Spiritual

Abernethy, Meraviglia, Murray, True, Silvestri 2003

0

Depression / Anxiety

Carlsen, Faller, Fox, Himelhoch, Krishnasamy Kuo,
Sarna 2005, Walker 2004, 2006,

1

Health Behavior Interventions

Denmark- Wahnefried, Hately, Ryan, Sugimura, Thompson,

Smoking Cessation

Baser, Cox 2002, Dillard, Evangelista, Gritz,
Sarna 2006, Schnoll 2002, 2003, 2004, Walker 2004, 2006

1

Physical

Ashley, Doorenbos, Lidstone, Smith 1996, Robb

0

Alcohol/Dietary

Ashley, Beach, Evangelista, Sarna 2006,

0

Scale -

o
1
2
3

no evidence or inadequate evidence
good evidence; not in lung cancer
good evidence; lung cancer patients
excellent evidence; lung cancer patients
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